Haleon (HLN) Receivables - Other (2021 - 2025)
Haleon's (HLN) quarterly Receivables - Other came in at $258.6 million in Q4 2025, down 24.54% YoY from $342.7 million in Q4 2024, and down 24.54% on a QoQ basis from $342.7 million in Q4 2024.
Haleon (HLN) Receivables - Other (2021 - 2025) Analysis & Trends
Haleon (HLN) has 5 years of Receivables - Other data on file, last reported at $258.6 million in Q4 2025.
- Quarterly Receivables - Other fell 24.54% year-over-year to $258.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $258.6 million (down 24.54% YoY) and the FY2025 annual result came in at $256.7 million, down 24.78% from the prior year.
- Receivables - Other fell to $258.6 million in Q4 2025, from $342.7 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $11.6 billion in Q2 2022 to a low of $258.6 million in Q4 2025.
- A 5-year average of $2.5 billion and a median of $449.4 million in 2022 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2022 — Receivables - Other plunged 76.11% — and 2023, when it slipped 14.89%.
- Tracing HLN's Receivables - Other over 5 years: stood at $2.0 billion in 2021, then sank by 76.11% to $485.6 million in 2022, then retreated by 14.89% to $413.3 million in 2023, then decreased by 17.08% to $342.7 million in 2024, then retreated by 24.54% to $258.6 million in 2025.
- The last three Receivables - Other figures came in at $258.6 million (Q4 2025), $342.7 million (Q4 2024), and $413.3 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 258.58 Mn |
| Dec 31, 2025 | 258.58 Mn |
| Dec 31, 2024 | 342.69 Mn |
| Dec 31, 2024 | 342.69 Mn |
| Dec 31, 2023 | 413.30 Mn |
| Dec 31, 2023 | 413.30 Mn |
| Dec 31, 2022 | 485.59 Mn |
| Dec 31, 2022 | 485.59 Mn |
| Jun 30, 2022 | 11.60 Bn |
| Jun 30, 2022 | 11.60 Bn |
| Dec 31, 2021 | 2.03 Bn |
| Dec 31, 2021 | 2.03 Bn |